Drug Trial Radar · NCT05275400
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
Last checked: Nov 20, 2026Latest source record: Jun 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
986
Actual
Start
Mar 8, 2022
Primary completion
May 15, 2024
Study completion May 15, 2024
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 11, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.
Conditions
- Type 2 Diabetes
Interventions
Insulin Efsitora AlfaDrug
Administered SC
Insulin DegludecDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) [Noninferiority]Time frame: Baseline, Week 26
Locations
127 sites in 10 countries. Site status is shown where the registry gives one.
Medical Investigations
Little Rock, Arkansas
John Muir Physician Network Research Center
Concord, California
AMCR Institute
Escondido, California
National Research Institute - Huntington Park
Huntington Park, California
Scripps Whittier Diabetes Institute
La Jolla, California
Diabetes Associates Medical Group
Orange, California
University Clinical Investigators, Inc.
Tustin, California
Chase Medical Research, LLC
Waterbury, Connecticut
Encore Medical Research
Hollywood, Florida
New Horizon Research Center
Miami, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
West Orange Endocrinology
Ocoee, Florida
Balanced Life Health Care Solutions/SKYCRNG
Lawrenceville, Georgia
Rocky Mountain Clinical Research
Idaho Falls, Idaho
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa
L-MARC Research Center
Louisville, Kentucky
Endocrine and Metabolic Consultants
Rockville, Maryland
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan
HealthPartners Institute dba International Diabetes Center
Minneapolis, Minnesota
SKY Clinical Research Network Group - Hall
Fayette, Mississippi
Clinvest Research LLC
Springfield, Missouri
Palm Research Center Tenaya
Las Vegas, Nevada
Albany Medical College, Division of Community Endocrinology
Albany, New York
NYC Research
New York, New York
Lillestol Research
Fargo, North Dakota
Aventiv Research Inc
Columbus, Ohio
Intend Research, LLC
Norman, Oklahoma
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania
Jefferson Clinical Research Institute (JCRI)
Philadelphia, Pennsylvania
Preferred Primary Care Physicians
Uniontown, Pennsylvania
Gadolin Research
Beaumont, Texas
Dallas Diabetes Research Center
Dallas, Texas
Juno Research
Houston, Texas
Biopharma Informatic, LLC
Houston, Texas
Southern Endocrinology Associates
Mesquite, Texas
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Rainier Clinical Research Center
Renton, Washington
CEMEDIC
Buenos Aires, Argentina
CENUDIAB
Ciudad Autónoma de Buenos Aire, Argentina
Showing 40 of 127 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.